Elastomeric Infusion Pumps Market is driven by rising chronic diseases prevalence
The Elastomeric Infusion Pumps market has seen significant growth in recent years owing to the growing prevalence of chronic diseases that require continuous infusion of drugs. Elastomeric infusion pumps are portable, light weight drug delivery devices that can deliver medicines slowly and continuously through needles or catheters. They find wide application in conditions like cancer, diabetes etc. that require long term pain management or administration of antibiotics. Advantages like programmable flow rates, accuracy in dosing and ease of use have made them a popular choice among patients.
The Global Elastomeric Infusion Pumps Market is estimated to be valued at US$ 446.31 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Elastomeric Infusion Pumps Market Share are Sika AG, BASF SE, Fosroc International Limited, Saint-Gobain Weber, The Euclid Chemical Company, Dayton Superior Corporation, WR Meadows, Specified Technologies Inc, TCC Materials and EMSEAL Joint Systems Ltd. Rising prevalence of chronic conditions like diabetes, cancer etc. has fueled the demand for continuous subcutaneous drug infusion devices in recent years. With increasing fitness awareness and lifestyle diseases, demand for elastomeric pumps is expected to grow further in the coming years. Geographically as well, the market is witnessing expansion with growing medical infrastructure and awarenss in developing regions of Asia Pacific and Latin America.
Gets More Insights on, Elastomeric Infusion Pumps Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian